drugset / Trial / NCT02650076

A Study to Investigate the Receptor Occupancy of SK-1405 in Healthy, Caucasian, Male Subjects

NCT02650076 ↗

Treatment

Summary

The primary objective is to confirm the target receptor occupancy of SK-1405 and to correlate receptor occupancy with SK-1405 dose and plasma concentration. The secondary objective is to assess the safety and tolerability of SK-1405 in healthy, Caucasian, male subjects.

Timeline

Start
2016-01
Primary completion
2016-04
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject SK-1405 Unknown — —

Indications

No indication recorded.